Medicare AdvantageCoverageMedium impact
MA11.105j, Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
Independence Blue Cross·Ophthalmology·Medical Policy
Effective date
Jul 9, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.105j for aqueous shunts, microstents, viscocanalostomy, and canaloplasty treatments for glaucoma has been reissued and will take effect July 9, 2025. This policy update affects coverage and billing requirements for glaucoma surgical procedures under Medicare Advantage plans.
Action Required
Before July 9, 2025: Billing team must review the complete policy MA11.105j to understand updated coverage criteria for glaucoma procedures including aqueous shunts, microstents, viscocanalostomy, and canaloplasty. Update prior authorization workflows and billing procedures for Medicare Advantage patients receiving these treatments. Coordinate with ophthalmology providers to ensure compliance with new requirements.